bioAffinity Technologies (BIAF) FCF Margin (2022 - 2026)
bioAffinity Technologies (BIAF) posted quarterly FCF Margin of 239.2% for Q1 2026, down 14789.0% year-over-year from N/an in Q1 2025, and down 48.86% quarter-over-quarter from 160.69% in Q4 2025.
bioAffinity Technologies (BIAF) FCF Margin (2022 - 2026) Analysis & Trends
bioAffinity Technologies (BIAF) has reported FCF Margin for 5 consecutive years, with 239.2% the latest figure, recorded in Q1 2026.
- In Q1 2026, FCF Margin fell 14789.0% year-over-year to 239.2%; the TTM figure through Mar 2026 stood at 193.11% (down 11763.0% YoY), while the FY2025 annual figure was 152.38%, down 7393.0% from the prior year.
- FCF Margin fell to 239.2% in Q1 2026 per BIAF's latest filing, from 160.69% in the prior quarter.
- Across five years, FCF Margin topped out at 65.09% in Q2 2024 and bottomed at 169528.23% in Q1 2023.
- Historically, FCF Margin has averaged 25968.94% across 5 years, with a median of 190.43% in 2025.
- Annual changes were most pronounced in 2024 — FCF Margin jumped 16942902 bps — and 2026, when it plunged 14789 bps.
- bioAffinity Technologies' FCF Margin stood at 55440.58% in 2022, then soared by 100 bps to 72.42% in 2023, then slipped by 5 bps to 75.97% in 2024, then tumbled by 112 bps to 160.69% in 2025, then plunged by 49 bps to 239.2% in 2026.
- Business Quant data shows BIAF's FCF Margin at 239.2% in Q1 2026, 160.69% in Q4 2025, and 171.27% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 13.97% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 20.19% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 26.51% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 10.95% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 8.24% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 2.59% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 13.89% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 27.51% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 15.08% |
| 10 | bioAffinity Technologies | 2.38 Mn | -721,990.64 | - | -239.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -239.20% |
| Dec 31, 2025 | -160.69% |
| Sep 30, 2025 | -171.27% |
| Jun 30, 2025 | -209.58% |
| Mar 31, 2025 | -91.31% |
| Dec 31, 2024 | -75.97% |
| Sep 30, 2024 | -73.12% |
| Jun 30, 2024 | -65.09% |
| Mar 31, 2024 | -99.21% |
| Dec 31, 2023 | -72.42% |
| Sep 30, 2023 | -513.49% |
| Jun 30, 2023 | -6,909.57% |
| Mar 31, 2023 | -169,528.23% |
| Dec 31, 2022 | -55,440.58% |
| Sep 30, 2022 | -153,052.26% |
| Jun 30, 2022 | -28,801.00% |